Merck & Company Inc. Common Stock (new) (MRK) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Merck & Company Inc. Common Stock (new) (MRK) carries a Roarable Rating of C+ (Hold) with 66/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How MRK Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $65.01B | 74.8% | 33.1% | $18.25B | $12.36B | 20.1% |
| FY 2024 | $64.17B | 76.3% | 31.5% | $17.12B | $18.10B | 23.6% |
| FY 2023 | $60.12B | 44% | 0.7% | $365.0M | $10.30B | 0.3% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring MRK)
- ✓Live walkthrough of MRK's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
MRK Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +1.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on MRK today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for MRK. Explore sector supply chains on /butterfly.
MRK Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Merck & Company Inc. Common Stock (new) (MRK)?
In FY 2025 (10-K), MRK converted $65.0B of revenue into a 74.8% gross margin, 33.1% operating margin, and $12.4B in free cash flow (19% FCF margin).